Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2003Cancer Control

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHilary ThomasPA Consulting GroupHCHelen M. ColeyBrighton and Sussex Medical School

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thomas et al. (2003) studied this question.

synapsesocial.com/papers/69df0fcad85e58e37b7a1156https://doi.org/10.1177/107327480301000207
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression2002 · 39 citations
  2. 2Phase I/II Study of the P-Glycoprotein Modulator PSC 833 in Patients With Acute Myeloid Leukemia2001 · 82 citations
  3. 3Phase II Study of Paclitaxel and Valspodar (PSC 833) in Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study2001 · 92 citations
  4. 4Improve or abandon the standardized response criteria for myelodysplastic syndromes recommended by the International Working Group2001 · 11 citations
  5. 5Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.1990 · 454 citations